ProfileGDS4718 / 243023_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 33% 78% 38% 44% 63% 61% 28% 26% 40% 48% 39% 34% 66% 60% 25% 35% 25% 56% 20% 30% 44% 27% 46% 56% 66% 49% 47% 37% 60% 36% 67% 22% 25% 34% 59% 66% 27% 27% 78% 32% 44% 29% 25% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0871742
GSM549102patient 115, normal, homogenized [OPG study]4.6748633
GSM549104patient 119, normal, homogenized [OPG study]7.7008478
GSM549108patient 138, normal, homogenized [OPG study]4.9464938
GSM549119patient 077, normal, homogenized [OPG study]5.198544
GSM549133patient 032, cancer, homogenized [OPG study]6.36163
GSM549139patient 042, cancer, homogenized [OPG study]6.188761
GSM549099patient 107, normal, homogenized [OPG study]4.4612928
GSM549109patient 139, normal, homogenized [OPG study]4.3964426
GSM549110patient 046, normal, homogenized [OPG study]5.0126540
GSM549114patient 063, normal, homogenized [OPG study]5.375948
GSM549122patient 082, normal, homogenized [OPG study]4.9550739
GSM549134patient 033, cancer, homogenized [OPG study]4.7127234
GSM549136patient 036, cancer, homogenized [OPG study]6.5669866
GSM549140patient 044, cancer, homogenized [OPG study]6.1153360
GSM549111patient 047, normal, homogenized [OPG study]4.3069125
GSM549113patient 057, normal, homogenized [OPG study]4.6973835
GSM549132patient 031, cancer, homogenized [OPG study]4.3364925
GSM549137patient 038, cancer, homogenized [OPG study]5.8960956
GSM549142patient 047, cancer, homogenized [OPG study]4.2457320
GSM549100patient 110, normal, homogenized [OPG study]4.5532730
GSM549107patient 135, normal, homogenized [OPG study]5.1544644
GSM549115patient 068, normal, homogenized [OPG study]4.3811527
GSM549116patient 072, normal, homogenized [OPG study]5.2425746
GSM549120patient 078, normal, homogenized [OPG study]5.8821756
GSM549131patient 030, cancer, homogenized [OPG study]6.5764866
GSM549118patient 074, normal, homogenized [OPG study]5.450149
GSM549129patient 027, cancer, homogenized [OPG study]5.3641447
GSM549123patient 088, normal, homogenized [OPG study]4.8478437
GSM549124patient 006, cancer, homogenized [OPG study]6.1428160
GSM549126patient 015, cancer, homogenized [OPG study]4.7889236
GSM549128patient 025, cancer, homogenized [OPG study]6.6963767
GSM549103patient 117, normal, homogenized [OPG study]4.259522
GSM549117patient 073, normal, homogenized [OPG study]4.3106125
GSM549138patient 041, cancer, homogenized [OPG study]4.6871334
GSM549141patient 045, cancer, homogenized [OPG study]6.0911959
GSM549130patient 028, cancer, homogenized [OPG study]6.5627266
GSM549101patient 111, normal, homogenized [OPG study]4.4486827
GSM549105patient 128, normal, homogenized [OPG study]4.4282427
GSM549106patient 134, normal, homogenized [OPG study]7.7915778
GSM549112patient 048, normal, homogenized [OPG study]4.6059632
GSM549125patient 011, cancer, homogenized [OPG study]5.1884244
GSM549127patient 024, cancer, homogenized [OPG study]4.4916629
GSM549135patient 035, cancer, homogenized [OPG study]4.272925